Magnesium Implants Release Hydrogen to Fight Ovarian Cancer
- Authors
- Shuang Qiao, Yongjie Wang, Rui Zan, Hongliu Wu, Yu Sun, Hongzhou Peng, Rui Zhang, Yang Song, Jiahua Ni, Shaoxiang Zhang, Xiaonong Zhang
- Journal
- ACS Biomaterials Science & Engineering
- Year
- 2020
- DOI
- 10.1021/acsbiomaterials.9b01703
- Study Type
- Mouse
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Epithelial Ovarian Cancer
- Body System
- Reproductive System
TL;DR
High-purity magnesium wires show potential as a treatment for ovarian cancer by inhibiting tumor growth and promoting cancer cell death.
Key Finding
Biodegradable magnesium implants and their breakdown products significantly inhibited ovarian cancer cell growth and promoted cancer cell death in mouse models and laboratory experiments.
Summary
Researchers tested whether magnesium implants (small metal devices that break down in the body) could slow the growth of ovarian cancer cells. Using mouse models and lab experiments, they found that magnesium implants and their breakdown products—including magnesium ions and hydrogen gas—reduced cancer cell growth and triggered cancer cell death. The results suggest magnesium implants might one day help treat ovarian cancer, especially in cases where chemotherapy drugs stop working.
Practical Takeaway
This is early-stage research in mice and lab dishes, not yet tested in humans. While the results are promising for a potential future cancer treatment, it's far too preliminary to draw any conclusions about hydrogen water or magnesium supplements for ovarian cancer. Many promising laboratory findings do not translate to human benefit, and anyone with ovarian cancer should discuss treatment options only with their oncologist.
Abstract
The common treatment of epithelial ovarian cancer is aggressive surgery followed by platinum-based cytotoxic chemotherapy. However, residual tumor cells are resistant to chemotherapeutic drugs during postoperative recurrence. The treatment of ovarian cancer requires new breakthroughs and advances. In recent years, magnesium alloy has been widely developed as a new biodegradable material because of its great potential in the field of medical devices. From the degradation products of magnesium, biodegradable magnesium implants have great potential in anti-tumor. According to the disease characteristics of ovarian cancer, we choose it to study the anti-tumor characteristics of biodegradable magnesium. We tested the anti-ovarian tumor properties of Mg through both in vivo and in vitro experiments. According to the optical in vivo imaging and relative tumor volume statistics of mice, high-purity Mg wires significantly inhibited the growth of SKOV3 cells in vivo. We find that the degradation products of Mg, Mg2+ and H2, significantly inhibit the growth of SKOV3 cells and promote their apoptosis. Our study suggests a good promise for treatment of ovarian cancer.